In this cohort study of a large, consecutive series of 8396 Chinese patients with primary invasive breast cancer in a single center, we investigated whether BRCA1/2 variant carriers could safely undergo BCT when the breast tumor was suitable for this procedure. Here, BRCA1 is linked to invasive breast carcinoma.